Literature DB >> 26102615

The Evolving Roles of Memory Immune Cells in Transplantation.

Wenhao Chen1, Rafik M Ghobrial, Xian C Li.   

Abstract

Memory cells are the products of immune responses but also exert significant impact on subsequent immunity and immune tolerance, thus placing them in a unique position in transplant research. Memory cells are heterogeneous, including not only memory T cells but also memory B cells and innate memory cells. Memory cells are a critical component of protective immunity against invading pathogens, especially in immunosuppressed patients, but they also mediate graft loss and tolerance resistance. Recent studies suggest that some memory cells unexpectedly act as regulatory cells, promoting rather than hindering transplant survival. This functional diversity makes therapeutic targeting of memory cells a challenging task in transplantation. In this article, we highlight recent advances in our understanding of memory cells, focusing on diversity of memory cells and mechanisms involved in their induction and functions. We also provide a broad overview on the challenges and opportunities in targeting memory cells in the induction of transplant tolerance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26102615      PMCID: PMC4591096          DOI: 10.1097/TP.0000000000000802

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  95 in total

1.  Homeostatic proliferation is a barrier to transplantation tolerance.

Authors:  Zihao Wu; Steven J Bensinger; Jidong Zhang; Chuangqi Chen; Xueli Yuan; Xiaolun Huang; James F Markmann; Alireza Kassaee; Bruce R Rosengard; Wayne W Hancock; Mohamed H Sayegh; Laurence A Turka
Journal:  Nat Med       Date:  2003-11-30       Impact factor: 53.440

Review 2.  Heterologous immunity and homeostatic proliferation as barriers to tolerance.

Authors:  Devon K Taylor; David Neujahr; Laurence A Turka
Journal:  Curr Opin Immunol       Date:  2004-10       Impact factor: 7.486

3.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

4.  Priming of memory but not effector CD8 T cells by a killed bacterial vaccine.

Authors:  G Lauvau; S Vijh; P Kong; T Horng; K Kerksiek; N Serbina; R A Tuma; E G Pamer
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

5.  Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms.

Authors:  Wentao Liu; Xiang Xiao; Gulcin Demirci; Joren Madsen; Xian C Li
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

Review 6.  Costimulatory pathways in transplantation: challenges and new developments.

Authors:  Xian C Li; David M Rothstein; Mohamed H Sayegh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

7.  Complement-binding anti-HLA antibodies and kidney-allograft survival.

Authors:  Alexandre Loupy; Carmen Lefaucheur; Dewi Vernerey; Christof Prugger; Jean-Paul Duong van Huyen; Nuala Mooney; Caroline Suberbielle; Véronique Frémeaux-Bacchi; Arnaud Méjean; François Desgrandchamps; Dany Anglicheau; Dominique Nochy; Dominique Charron; Jean-Philippe Empana; Michel Delahousse; Christophe Legendre; Denis Glotz; Gary S Hill; Adriana Zeevi; Xavier Jouven
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

8.  Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets.

Authors:  Taheri Sathaliyawala; Masaru Kubota; Naomi Yudanin; Damian Turner; Philip Camp; Joseph J C Thome; Kara L Bickham; Harvey Lerner; Michael Goldstein; Megan Sykes; Tomoaki Kato; Donna L Farber
Journal:  Immunity       Date:  2012-12-20       Impact factor: 31.745

9.  Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation.

Authors:  Tsukasa Nabekura; Lewis L Lanier
Journal:  J Exp Med       Date:  2014-11-03       Impact factor: 14.307

10.  Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.

Authors:  Tim A Weaver; Ali H Charafeddine; Avinash Agarwal; Alexandra P Turner; Maria Russell; Frank V Leopardi; Robert L Kampen; Linda Stempora; Mingqing Song; Christian P Larsen; Allan D Kirk
Journal:  Nat Med       Date:  2009-07-05       Impact factor: 53.440

View more
  7 in total

1.  Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells.

Authors:  Elodie Picarda; Séverine Bézie; Laetitia Boucault; Elodie Autrusseau; Stéphanie Kilens; Dimitri Meistermann; Bernard Martinet; Véronique Daguin; Audrey Donnart; Eric Charpentier; Laurent David; Ignacio Anegon; Carole Guillonneau
Journal:  JCI Insight       Date:  2017-02-09

2.  Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells.

Authors:  D V Mathews; W C Wakwe; S C Kim; M C Lowe; C Breeden; M E Roberts; A B Farris; E A Strobert; J B Jenkins; C P Larsen; M L Ford; R Townsend; A B Adams
Journal:  Am J Transplant       Date:  2017-07-11       Impact factor: 8.086

Review 3.  Adaptive features of innate immune cells and their relevance to graft rejection.

Authors:  Guangchuan Wang; Gangcheng Kong; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2019-12       Impact factor: 2.640

4.  Ablation of interferon regulatory factor 4 in T cells induces "memory" of transplant tolerance that is irreversible by immune checkpoint blockade.

Authors:  Hedong Zhang; Jie Wu; Dawei Zou; Xiang Xiao; Hui Yan; Xian C Li; Wenhao Chen
Journal:  Am J Transplant       Date:  2018-12-25       Impact factor: 8.086

5.  T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation.

Authors:  Aini Xie; Hui Yan; Jinfei Fu; Adam He; Xiang Xiao; Xian C Li; Wenhao Chen
Journal:  J Heart Lung Transplant       Date:  2019-11-26       Impact factor: 10.247

6.  Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.

Authors:  Caroline Pilon; Jeremy Bigot; Cynthia Grondin; Allan Thiolat; Philippe Lang; José L Cohen; Philippe Grimbert; Marie Matignon
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

7.  Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness.

Authors:  Anne P Bouvy; Mariska Klepper; Michiel G H Betjes; Willem Weimar; Dennis A Hesselink; Carla C Baan
Journal:  Transplant Direct       Date:  2016-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.